Baffa O, Cora L, Americo M, Fonseca P, Oliveira R, A Miranda J
Department of Physics and Mathematics, FFCLRP, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Conf Proc IEEE Eng Med Biol Soc. 2005;2005:7254-7. doi: 10.1109/IEMBS.2005.1616185.
Oral administration with solid dosage forms is a common route in the drug therapy widely used. The drug release by the disintegration process occurs in several gastrointestinal tract (GIT) regions. AC Biosusceptometry (ACB) was originally proposal to characterize the disintegration process of tablets in vitro and in the human stomach, through changes in magnetic signals. The aim of this work was to employ a multisensor ACB system to monitoring magnetic tablets and capsules in the human GIT and to obtain the magnetic images of the disintegration process. The ACB showed accuracy to quantify the gastric residence time, the intestinal transit time and the magnetic images allowed to visualize the disintegration of magnetic formulations in the GIT. The ACB is a non-invasive, radiation free technique, completely safe and harmless to the volunteers and had demonstrated potential to evaluate pharmaceutical dosage forms in the human gastrointestinal tract.
口服固体剂型是药物治疗中广泛使用的常见给药途径。药物通过崩解过程在胃肠道的几个区域释放。交流生物电阻抗测定法(ACB)最初是为了通过磁信号的变化来表征片剂在体外和人胃中的崩解过程而提出的。这项工作的目的是采用多传感器ACB系统来监测人体胃肠道中的磁性片剂和胶囊,并获得崩解过程的磁图像。ACB能够准确量化胃滞留时间、肠道转运时间,磁图像能够直观显示胃肠道中磁性制剂的崩解情况。ACB是一种非侵入性、无辐射的技术,对志愿者完全安全无害,并且已证明有潜力评估人体胃肠道中的药物剂型。